Author

Christina Reimer

PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION AT TWO YEARS AFTER TREATMENT WITH INVESTIGATIONAL MICROBIOTA-BASED DRUG RBX2660: EFFICACY, DURABILITY, MICROBIOME CHANGES, AND PARTICIPANT DEMOGRAPHICS OF A PHASE 2 OPEN-LABEL CLINICAL TRIAL
PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION AT TWO YEARS AFTER TREATMENT WITH INVESTIGATIONAL MICROBIOTA-BASED DRUG RBX2660: EFFICACY, DURABILITY, MICROBIOME CHANGES, AND PARTICIPANT DEMOGRAPHICS OF A PHASE 2 OPEN-LABEL CLINICAL TRIAL

Christina Reimer  et al.

Item 1 - 1 / 1
1